Table 1 Demographics and clinical characteristics of patients with Kawasaki disease shock syndrome and Kawasaki disease (continuous variables were described as median and range)
From: Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study
KDSS (n=13) | KD (n=91) | P value | |
|---|---|---|---|
Age, (years) | 5.1 (0.5–10.6) | 2.3 (0.2–8.4) | 0.000 |
Male (%) | 46.2% (6/13) | 58.2% (53/91) | 0.411 |
Fever duration (days) | 11 (8–23) | 8 (3–29) | 0.002 |
Total hospital day (days) | 18 (6–31) | 6 (3–18) | 0.000 |
Follow up duration (months) | 10 (1–105) | 13 (0–175) | 0.723 |
ICU care (%) | 53.8% (7/13) | 0.0% (0/91) | 0.000 |
ICU care duration (days) | 4 (0–11) | 0 | 0.000 |
Inotropic drugs (%) | 92.3% (12/13)§ | 1.1% (1/91) | 0.000 |
Respiratory support | |||
- No support | 30.8% (4/13) | 100% (91/91) | 0.000 |
- Oxygen delivery | 53.8% (7/13) | 0.0% (0/91) | 0.000 |
- Mechanical ventilation | 15.4% (2/13) | 0.0% (0/91) | 0.015 |
Mortality (%) | 0.0% (0/13) | 0.0% (0/91) | |